Tatevik Balayan
YOU?
Author Swipe
View article: Differences in integrated assessment and management of non‐communicable diseases (<scp>NCDs</scp>) for people with <scp>HIV</scp> across the <scp>WHO</scp> European region
Differences in integrated assessment and management of non‐communicable diseases (<span>NCDs</span>) for people with <span>HIV</span> across the <span>WHO</span> European region Open
Objectives We aimed to assess the extent of integration of non‐communicable disease (NCD) assessment and management in HIV clinics across Europe. Methods A structured electronic questionnaire with 41 multiple‐choice and rating‐scale questi…
View article: Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group
Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group Open
(1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare…
View article: PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future
PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future Open
With no expected vaccine for HIV in the near future, we aimed to define the current situation and challenges for pre- and post-exposure prophylaxis (PrEP and PEP) in Central and Eastern Europe (CEE). The Euroguidelines CEE Network Group me…
View article: Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network
Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network Open
Chronic kidney disease (CKD) is a significant cause of morbidity and mortality among patients infected with human immunodeficiency virus (HIV). The Central and East Europe (CEE) region consists of countries with highly diversified HIV epid…
View article: The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group
The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group Open
Introduction: The COVID-19 pandemic has been challenging time for medical care, especially in the field of infectious diseases (ID), but it has also provided an opportunity to introduce new solutions in HIV management. Here, we investigate…
View article: National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region
National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region Open
Introduction People living with HIV (PLWH) are at higher risk of poorer COVID‐19 outcomes. Vaccination is a safe and effective method of prevention against many infectious diseases, including COVID‐19. Here we investigate the strategies fo…
View article: Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group
Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group Open
Objectives Pre‐exposure prophylaxis (PrEP) for HIV infection is an important intervention for control of the HIV epidemic. The incidence of HIV infection is increasing in the countries of Central and Eastern Europe (CEE). Therefore, we inv…
View article: HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?
HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe? Open
A shortage of resources is evident, with an impact on HIV care inevitable. We need to prepare to operate with minimal medical resources, with the aim of securing constant supplies of ART. Non-governmental organizations should re-evaluate t…
View article: Adherence to aniretroviral treatment and knowledge on HIV/AIDS among the people living with HIV in Armenia
Adherence to aniretroviral treatment and knowledge on HIV/AIDS among the people living with HIV in Armenia Open
View article: HIV care in Central and Eastern Europe: How close are we to the target?
HIV care in Central and Eastern Europe: How close are we to the target? Open
There are major disparities in the provision of HIV care among sub-regions in Europe, which should be addressed. More attention in terms of funding, knowledge and experience sharing, and capacity building is required for the resource-limit…
View article: Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review
Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review Open
Background . Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART). Methods . We systematically reviewe…
View article: Common intestinal infectious diseases in the Republic of Armenia
Common intestinal infectious diseases in the Republic of Armenia Open
Purpose: The group of common intestinal infectious diseases (dysentery, yersiniosis, acute intestinal infections with unknown etiology, gastroenterocolitis with known etiology, enterovirus and rotavirus infections, nutritional toxicoinfect…
View article: Risky behavior among MSM in Armenia
Risky behavior among MSM in Armenia Open